Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas

Ovarian Cancer Biomarkers: Current Options and Future Promise

(2017) Christine M. Coticchia et al.   Journal of the National Comprehensive Cancer Network

Angiotensin-Converting Enzyme-Induced Activation of Local Angiotensin Signaling Is Required for Ascending Aortic Aneurysms in Fibulin-4-Deficient Mice

(2013) J. Huang et al.   Science Translational Medicine

Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis

(2012) Yves Henrotin et al.   ARTHRITIS AND RHEUMATISM

Advances in Biomarker Research for Pancreatic Cancer

(2012) Kruttika Bhat et al.   CURRENT PHARMACEUTICAL DESIGN

Cutis laxa: A review

(2012) David R. Berk et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma

(2012) Harvey I. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal Metastasis

(2012) Jianming Ying et al.   PLoS One

EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment

(2011) Yuanjie Hu et al.   Molecular Cancer

Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma

(2011) Mitsuro Kanda et al.   MOLECULAR CARCINOGENESIS

Tumor angiogenesis: molecular pathways and therapeutic targets

(2011) Sara M Weis et al.   NATURE MEDICINE

Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma

(2011) E W L Law et al.   ONCOGENE

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Loss of fibulin-5 binding to  1 integrins inhibits tumor growth by increasing the level of ROS

(2010) M. K. Schluterman et al.   Disease Models & Mechanisms

The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis

(2010) Song En-lin et al.   GYNECOLOGIC ONCOLOGY

EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo

(2010) En-lin Song et al.   GYNECOLOGIC ONCOLOGY

Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity

(2010) Chung-Feng Hwang et al.   JOURNAL OF PATHOLOGY

Serum tumour markers in gynaecological cancers

(2010) Pakhee Aggarwal et al.   MATURITAS

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma

(2010) Ettie Piura et al.   Journal of Oncology

Fibulin-5 Suppresses Lung Cancer Invasion by Inhibiting Matrix Metalloproteinase-7 Expression

(2009) W. Yue et al.   CANCER RESEARCH

Fibulins: Multiple roles in matrix structures and tissue functions

(2009) S. de Vega et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma

(2009) H. Seeliger et al.   MOLECULAR CANCER RESEARCH

Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion

(2009) B. Hu et al.   MOLECULAR CANCER RESEARCH

Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637

(2009) Zheng Hu et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Fibulin-5, an integrin-binding matricellular protein: its function in development and disease

(2009) Hiromi Yanagisawa et al.   Journal of Cell Communication and Signaling

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer

(2008) Y Y Cheng et al.   BRITISH JOURNAL OF CANCER

Basement Membrane Derived Fibulin-1 and Fibulin-5 Function as Angiogenesis Inhibitors and Suppress Tumor Growth

(2008) Liang Xie et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

(2008) Ariane Sadr-Nabavi et al.   INTERNATIONAL JOURNAL OF CANCER

Integrin β3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones

(2008) Jie Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY